Cipher Pharmaceuticals Inc.
CPHRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $246,468 | $104,770 | $70,924 | $37,503 |
| - Cash | $17,837 | $39,825 | $28,836 | $20,548 |
| + Debt | $40,578 | $353 | $428 | $516 |
| Enterprise Value | $269,209 | $65,298 | $42,516 | $17,471 |
| Revenue | $33,363 | $21,162 | $20,675 | $21,943 |
| % Growth | 57.7% | 2.4% | -5.8% | – |
| Gross Profit | $24,103 | $17,093 | $16,683 | $18,259 |
| % Margin | 72.2% | 80.8% | 80.7% | 83.2% |
| EBITDA | $11,865 | $11,529 | $11,951 | $13,659 |
| % Margin | 35.6% | 54.5% | 57.8% | 62.2% |
| Net Income | $11,545 | $20,383 | $26,636 | $7,758 |
| % Margin | 34.6% | 96.3% | 128.8% | 35.4% |
| EPS Diluted | 0.46 | 0.8 | 0.99 | 0.29 |
| % Growth | -42.5% | -19.2% | 241.4% | – |
| Operating Cash Flow | $19,546 | $15,999 | $10,575 | $13,814 |
| Capital Expenditures | -$42 | -$21 | -$81 | $0 |
| Free Cash Flow | $19,502 | $15,978 | $10,494 | $13,814 |